<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF InhibitorsFei Su, Jeffrey A. Sosman, Jorge S. Reis‐Filho et al.|New England Journal of Medicine|2012Cited by 1k
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomasFelipe C. Geyer, Jorge S. Reis‐Filho|Nature Communications|2018Cited by 138
Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancerMothaffar F. Rimawi, Rachel Schiff, Carmine De Angelis et al.|Breast Cancer Research and Treatment|2017Cited by 95